Griffith Kundahl, a former general counsel with the NanoBusiness Alliance, is the new executive director of the Center of Innovation for Nanobiotechnology, or COIN.

COIN is based in Durham and is a relatively new organization focused on commercialization of nanobiotechnology in North Carolina.

Brooks Adams had been the group’s executive director. He resigned March 8, according to a COIN spokesperson.

Kundahal’s appointment was effective as of Aug. 23, COIN said in a press release.

“As Executive Director of COIN, Griff will direct a talented team, and a broad base of stakeholders focused on stimulating the commercialization of nanobiotechnologies, locally, nationally and internationally,” says Roger Cubicciotti, chairman of the COIN Board of Directors. He also is president of Nanomedica Inc.

In a statement, Kundahl said COIN “will focus our efforts to hasten commercial development in this field which holds such tremendous potential for improving the human condition via breakthrough innovations in healthcare, energy, agriculture and the environment.”

Kundahl has also served as executive chairman of the Colorado Nanotechnology Alliance and vice president for Convergence (nano, bio and IT) in the Life Sciences section of Ogilvy Public Relations Worldwide. His most recent position was director of global programs for the University of Denver School of Engineering and Computer Science.

A graduate of the University of Pennsylvania, he earned a law degree at the University of Denver and a master’s degree at the University of Alabama.

COIN is co-hosting an international conference on nanotechnology and microtechnology from Aug. 28-31 in Greensboro. The COMS conference stands for Commercialization of Micro-Nano Systems.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.